Asthma and care during a coronavirus pandemic

Detalhes bibliográficos
Autor(a) principal: Santos Lins de Oliveira, Guilherme
Data de Publicação: 2021
Outros Autores: Cavalcanti Pires de Azevedo, Thomás, Aguiar Costa, Rayane, Gomes de Mendonça Vasconcelos, Júlia Maria, Monteiro da Cruz, Cristiane, Reis Gonçalves, Marcos
Tipo de documento: Artigo
Idioma: por
Título da fonte: Vittalle (Online)
Texto Completo: https://periodicos.furg.br/vittalle/article/view/12374
Resumo: The new coronavirus, discovered in December 2019, is the causative agent of severe pneumonia that has spawned a global pandemic. The recognition of risk and protection factors are essential to guide the follow-up of new treatments and infection prevention strategies. This study aims to assess the influence of asthma against the pandemic due to the new coronavirus, with regard to the pathophysiology of pathological conditions, risk factors, therapeutic forms, associated comorbidities and the current protocols that are being used in such a scenario. The study is based on an integrative research of narrative literature review. In order to establish the relationship between asthma and COVID-19, articles published in the years 2019 and 2020 were limited to the PubMed and BVS virtual libraries. Asthma is a chronic respiratory disease characterized by inflammation of the airways, hyperresponsiveness, exacerbated mucus production and remodeling. The most frequent trigger of the pathology is airway infection, especially of viral origin. The asthmatic patient's innate immune system is unable to prevent the spread of these viruses to the lower respiratory tract. Currently, the Center for Disease Control and Prevention and the World Health Organization suggest that patients with moderate and severe asthma may be at higher risk for severe cases of SARS-CoV-2 infection, however, in the literature, there are no findings that corroborate. Therefore, he sees that the study and new associations must be continued, in order to better understand the relationship between asthma and COVID-19.   Keywords: COVID-19. Asthma. Risk factor.
id FURG-6_1ee8a69bb11c28947153cfe28d8aec6c
oai_identifier_str oai:periodicos.furg.br:article/12374
network_acronym_str FURG-6
network_name_str Vittalle (Online)
repository_id_str
spelling Asthma and care during a coronavirus pandemicReflexo da COVID-19 em asmáticosCOVID-19asmafator de riscoThe new coronavirus, discovered in December 2019, is the causative agent of severe pneumonia that has spawned a global pandemic. The recognition of risk and protection factors are essential to guide the follow-up of new treatments and infection prevention strategies. This study aims to assess the influence of asthma against the pandemic due to the new coronavirus, with regard to the pathophysiology of pathological conditions, risk factors, therapeutic forms, associated comorbidities and the current protocols that are being used in such a scenario. The study is based on an integrative research of narrative literature review. In order to establish the relationship between asthma and COVID-19, articles published in the years 2019 and 2020 were limited to the PubMed and BVS virtual libraries. Asthma is a chronic respiratory disease characterized by inflammation of the airways, hyperresponsiveness, exacerbated mucus production and remodeling. The most frequent trigger of the pathology is airway infection, especially of viral origin. The asthmatic patient's innate immune system is unable to prevent the spread of these viruses to the lower respiratory tract. Currently, the Center for Disease Control and Prevention and the World Health Organization suggest that patients with moderate and severe asthma may be at higher risk for severe cases of SARS-CoV-2 infection, however, in the literature, there are no findings that corroborate. Therefore, he sees that the study and new associations must be continued, in order to better understand the relationship between asthma and COVID-19.   Keywords: COVID-19. Asthma. Risk factor.O novo coronavírus, descoberto em dezembro de 2019, é o agente causador da pneumonia grave que gerou uma pandemia global. O reconhecimento dos fatores de risco e proteção são essenciais para direcionar o seguimento de novos tratamentos e estratégias de prevenção de infecções. Este estudo tem como objetivo avaliar a influência da asma frente a pandemia pelo novo coronavírus, no que tange à fisiopatologia dos quadros patológicos, aos fatores de risco, às formas terapêuticas, às comorbidades associadas e aos atuais protocolos que estão sendo utilizados em tal cenário. O estudo baseia-se em uma pesquisa descritiva de revisão integrativa da literatura. Limitou-se, para estabelecer a relação da asma e COVID-19, artigos publicados nos anos de 2019 e 2020, nas bibliotecas virtuais PubMed e BVS. Asma é uma doença respiratória crônica caracterizada pela inflamação das vias aéreas, hiper-responsividade, produção exacerbada de muco e remodelação. O gatilho mais frequente da patologia é a infecção das vias aéreas, especialmente de origem viral. O sistema imunológico inato do paciente asmático é incapaz de impedir a disseminação desses vírus para as vias respiratórias inferiores. Atualmente, o Centro de Controle e Prevenção de Doenças e a Organização Mundial de Saúde sugerem que pacientes com asma moderada e grave podem estar em maior risco para os casos graves de infecção pelo SARS-CoV-2, entretanto, na literatura, não há achados que corroboram. Sendo assim, vê que o estudo e novas associações devem ser continuados, a fim de melhor compreender a relação entre a asma e a COVID-19.Universidade Federal do Rio Grande2021-08-09info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://periodicos.furg.br/vittalle/article/view/1237410.14295/vittalle.v33i2.12374VITTALLE - Revista de Ciências da Saúde; v. 33 n. 2 (2021); 12 - 192177-78531413-3563reponame:Vittalle (Online)instname:Universidade Federal do Rio Grande (FURG)instacron:FURGporhttps://periodicos.furg.br/vittalle/article/view/12374/8952Copyright (c) 2021 VITTALLE - Revista de Ciências da Saúdeinfo:eu-repo/semantics/openAccessSantos Lins de Oliveira, GuilhermeCavalcanti Pires de Azevedo, ThomásAguiar Costa, Rayane Gomes de Mendonça Vasconcelos, Júlia MariaMonteiro da Cruz, CristianeReis Gonçalves, Marcos2021-08-09T14:05:14Zoai:periodicos.furg.br:article/12374Revistahttps://periodicos.furg.br/vittallePUBhttps://periodicos.furg.br/vittalle/oaivittalle@furg.br2177-78531413-3563opendoar:2021-08-09T14:05:14Vittalle (Online) - Universidade Federal do Rio Grande (FURG)false
dc.title.none.fl_str_mv Asthma and care during a coronavirus pandemic
Reflexo da COVID-19 em asmáticos
title Asthma and care during a coronavirus pandemic
spellingShingle Asthma and care during a coronavirus pandemic
Santos Lins de Oliveira, Guilherme
COVID-19
asma
fator de risco
title_short Asthma and care during a coronavirus pandemic
title_full Asthma and care during a coronavirus pandemic
title_fullStr Asthma and care during a coronavirus pandemic
title_full_unstemmed Asthma and care during a coronavirus pandemic
title_sort Asthma and care during a coronavirus pandemic
author Santos Lins de Oliveira, Guilherme
author_facet Santos Lins de Oliveira, Guilherme
Cavalcanti Pires de Azevedo, Thomás
Aguiar Costa, Rayane
Gomes de Mendonça Vasconcelos, Júlia Maria
Monteiro da Cruz, Cristiane
Reis Gonçalves, Marcos
author_role author
author2 Cavalcanti Pires de Azevedo, Thomás
Aguiar Costa, Rayane
Gomes de Mendonça Vasconcelos, Júlia Maria
Monteiro da Cruz, Cristiane
Reis Gonçalves, Marcos
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Santos Lins de Oliveira, Guilherme
Cavalcanti Pires de Azevedo, Thomás
Aguiar Costa, Rayane
Gomes de Mendonça Vasconcelos, Júlia Maria
Monteiro da Cruz, Cristiane
Reis Gonçalves, Marcos
dc.subject.por.fl_str_mv COVID-19
asma
fator de risco
topic COVID-19
asma
fator de risco
description The new coronavirus, discovered in December 2019, is the causative agent of severe pneumonia that has spawned a global pandemic. The recognition of risk and protection factors are essential to guide the follow-up of new treatments and infection prevention strategies. This study aims to assess the influence of asthma against the pandemic due to the new coronavirus, with regard to the pathophysiology of pathological conditions, risk factors, therapeutic forms, associated comorbidities and the current protocols that are being used in such a scenario. The study is based on an integrative research of narrative literature review. In order to establish the relationship between asthma and COVID-19, articles published in the years 2019 and 2020 were limited to the PubMed and BVS virtual libraries. Asthma is a chronic respiratory disease characterized by inflammation of the airways, hyperresponsiveness, exacerbated mucus production and remodeling. The most frequent trigger of the pathology is airway infection, especially of viral origin. The asthmatic patient's innate immune system is unable to prevent the spread of these viruses to the lower respiratory tract. Currently, the Center for Disease Control and Prevention and the World Health Organization suggest that patients with moderate and severe asthma may be at higher risk for severe cases of SARS-CoV-2 infection, however, in the literature, there are no findings that corroborate. Therefore, he sees that the study and new associations must be continued, in order to better understand the relationship between asthma and COVID-19.   Keywords: COVID-19. Asthma. Risk factor.
publishDate 2021
dc.date.none.fl_str_mv 2021-08-09
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://periodicos.furg.br/vittalle/article/view/12374
10.14295/vittalle.v33i2.12374
url https://periodicos.furg.br/vittalle/article/view/12374
identifier_str_mv 10.14295/vittalle.v33i2.12374
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://periodicos.furg.br/vittalle/article/view/12374/8952
dc.rights.driver.fl_str_mv Copyright (c) 2021 VITTALLE - Revista de Ciências da Saúde
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2021 VITTALLE - Revista de Ciências da Saúde
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal do Rio Grande
publisher.none.fl_str_mv Universidade Federal do Rio Grande
dc.source.none.fl_str_mv VITTALLE - Revista de Ciências da Saúde; v. 33 n. 2 (2021); 12 - 19
2177-7853
1413-3563
reponame:Vittalle (Online)
instname:Universidade Federal do Rio Grande (FURG)
instacron:FURG
instname_str Universidade Federal do Rio Grande (FURG)
instacron_str FURG
institution FURG
reponame_str Vittalle (Online)
collection Vittalle (Online)
repository.name.fl_str_mv Vittalle (Online) - Universidade Federal do Rio Grande (FURG)
repository.mail.fl_str_mv vittalle@furg.br
_version_ 1797041721215811584